Newtopia Reports First Quarter 2021 Financial Results

  • Q1 2021 Revenue of $2.6 million, in line with expectations
  • Q1 2021 Gross Margin[1] of 50%, a 700 basis point improvement over the prior-year period
  • Marked one-year listing anniversary on the TSXV on May 4, 2021
  • Continued to strengthen robust innovator employer business pipeline, while broadening reach into additional public health insurer markets in the US and Canada

 

TORONTO, ONTARIO – May 20, 2021, Newtopia Inc. (“Newtopia” or the “Company”) (TSXV: NEWU), a tech-enabled habit change provider focused on disease prevention, today reported financial results for the first quarter 2021. All amounts are expressed in Canadian dollars, unless otherwise noted.

 

First Quarter 2021 Financial Highlights (vs. Q1 2020):

  • Revenue of $2.6 million, as compared to $3.9 million
  • Gross margin percentage of 50%, up from 43%

 

“The pandemic has proven the importance of prevention as a means of protecting our global population. Specifically, we continue to see strong engagement levels for our whole person care and participant churn remains at historically low levels. Interestingly, participants who joined our platform right as the pandemic began have outperformed our traditional participant,” said Jeff Ruby, Founder & CEO of Newtopia. “We are looking forward to the return to year-over-year growth, with a rollout with one of our Fortune 500 clients that was previously postponed now scheduled for the back half of the year, and a pipeline of new clients building.”

 

Ruby continued, “The first quarter marked a significant expansion of Newtopia’s health insurer focus and addressable market as we bring our proven disease prevention model to both the US and Canada for Medicare and provincial health customers, respectively. We anticipate a tsunami of chronic disease risk following COVID-19 and look forward to supporting our clients with a proven means of addressing this mounting issue. With increased vaccination counts across North America, and in particular the United States, we are hopeful that our clients will return to their standard operating procedures. Our underlying business remains strong, and we look forward to supporting current and prospective clients hoping to mitigate their risks as the world economy fully reopens.”

 

Recent Operational Highlights:

 

  • Debuted Habit Change Platform in Canada in April through a partnership with Eastern Health, the largest, integrated health authority in Newfoundland and Labrador, and Medtronic, a formal partner under Eastern Health’s Innovation Strategy. Together, Newtopia and its two partners will implement an integrated type 2 diabetes prevention program.
  • Launched Phase 1 – the first six months – of a campaign with a Fortune 500 apparel and home fashion chain in the United States employing 90,000 people, with the opportunity to expand to the entire at-risk population.
  • Completed a 12-month JPMorgan Chase Medical Trial sponsored by Haven. Results of this study will be formally published in the coming weeks.
  • Expanded Company Advisory Board to include Nancy Cocozza, Former President of Aetna Medicare, and Gil Bashe, Global Head of Health at FINN Partners, a leading global marketing agency.
  • Officially commenced sales efforts into the Medicare and Medicare Advantage (“MA”) markets following a successful study conducted by Santa Barbara Actuaries Inc. and commissioned by Newtopia. Results of the Santa Barbara Actuaries study demonstrate that Newtopia’s programs can provide significant medical cost savings of up to $1,700 per MA member. Adding this particular at-risk population to the Newtopia platform expands the Company’s potential target base into the 65 years and older Medicare and MA markets, which together represent 62 million people.

 

Newtopia’s platform leverages genetic, social and behavioral insights to create individualized prevention programs. The Company’s whole person approach combines virtual care, digital tools, connected devices and actionable data science to assist in preventing, slowing and reversing chronic disease while also enriching mental and emotional health. Newtopia helps generate sustainable habit change for participants while maintaining clinical and financial outcomes for health insurers.

 

First Quarter 2021 Financial Results

 

Revenue for the three months ended March 31, 2021 was $2.6 million, compared to $3.9 million in the prior-year period. In the first quarter of 2021, revenue was comprised of 77% engagement fee revenue, up from 64% in the prior-year period.

 

Gross profit for the first quarter 2021 totaled $1.3 million, as compared to $1.7 million in the prior-year period. Gross profit is comprised of Newtopia’s revenue less direct expenses, which include the cost of Welcome Kits sold to new participants as well as labour costs associated with hiring and training of the Company’s coaching team of Inspirators. As a percentage of revenue, gross profit totaled 50%, up from 43% in the first quarter of 2020.

 

Selling, general and administrative expenses totaled $2.2 million, as compared to $1.7 million in the prior-year period. Selling, general and administrative expenses included approximately $0.1 million in search costs related to sales and technology hires in the quarter that will not recur in future periods.

 

Adjusted operating expenses[2] for the three months ended March 31, 2021 totaled $2.9 million, compared to $2.4 million in the prior-year period, as the Company continued to add technology, sales and marketing and administrative resources to support long-term growth.

 

For the quarter, the Company had an adjusted operating loss[3] of $1.6 million, compared to an adjusted operating loss of $0.8 million in the prior-year period. This increase in adjusted operating loss is due to the lower level of revenue in this year’s first quarter along with the corresponding lower margin.

 

The Company ended the first quarter 2021 with $2.6 million in cash on the balance sheet. During the quarter, Newtopia incurred $0.5 million in capital expenditures and approximately $0.5 million of additional non-recurring public company costs and recruitment search fees. The Company has not utilized its credit facility to date.

 

2021 Outlook

In the first quarter of each calendar year Newtopia typically experiences higher rates of new product launches, with a corresponding increase in Welcome Kit and engagement revenues. As a result of the COVID-19 pandemic, the Company underwent a delayed rollout of its products to some of its clients in Q1 2021. As a result, Newtopia continues to anticipate revenue to hold relatively steady through the second quarter 2021, with an increase in topline growth in the third and fourth quarters. While new product rollouts may be softer in the first half of the year, the Company’s multi-year contracts with its clients and overall underlying business is very healthy with record levels of engagement.

 

The Company also continues to expect approximately $1.8 million of capital expenditures in 2021, with approximately $0.5 million incurred to date. The remaining $1.3 million will be capitalized over the course of 2021 and weighted toward the first three quarters of the year. This spend will be directed toward improving the efficiency of Newtopia’s operations by leveraging new and improved engagement technologies to elevate the overall user experience. Newtopia continues to take a measured approach to adding expenses in support of growth, and increases in expenses have been more modest than the Company’s growth in revenue and gross profit. As such, even with this increase in capital expenditures in 2021, Newtopia continues to target exiting the year cash flow neutral from operations.

 

Grants of Stock Options

 

Newtopia further announced today that its Board of Directors has approved the grant of 1,312,200 stock options to certain tenured employees, directors, consultants and newly hired employees. The options issued to newly hired employees will expire five years from the date such employees complete their probationary period, and the exercise price will be based on the closing price of Newtopia common shares on the trading day prior to the day these employees complete their probationary period. Options granted to directors and tenured employees will be at an exercise price of $0.47 per common share and will expire on May 19, 2026, being five years from the grant date.

 

Newtopia can grant up to 18,114,870 stock options pursuant to its stock option plan, representing approximately 20% of the aggregate of the issued and outstanding common shares of the Company on the date the Company’s common shares were listed for trading on the TSX Venture Exchange on May 4, 2020. Including the grants contemplated herein, Newtopia will have 16,575,967 stock options outstanding.

 

Zooming with LD Micro

 

Tomorrow, May 21, 2021, at 11 AM ET, management will discuss the first quarter and other Company developments on a public webcast hosted by LD Micro. For those interested in listening to the webcast, please visit the following Zoom link roughly five minutes prior to the scheduled presentation time to register for the event: https://us02web.zoom.us/webinar/register/WN_OcL1BP16SDClwim1gclDbQ.

 

For those unable to listen to the live event, a replay link will be posted to the investor relations’ section of the Company’s website at www.newtopia.com. An updated corporate presentation including Newtopia’s Q1 2021 financials will be available on the Company’s website ahead of the webcast. Newtopia’s Q1 2021 financial statements will also be available on the website and under the Company’s profile at www.sedar.com.

 

About Newtopia

 

Newtopia is a tech-enabled habit change provider focused on disease prevention and reducing the cost of care for health insurers. As a provider of whole person care, we prevent, reverse and slow the progression of chronic disease while enriching mental health, resilience and overall human performance. Newtopia’s programs leverage genetic, social and behavioral insights to create individualized prevention programs with a focus on type 2 diabetes, heart disease, stroke and weight. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, Newtopia delivers sustainable clinical and financial outcomes. Newtopia serves some of the largest nationwide employers and health plans and is currently listed on the Toronto Stock Exchange (TSXV: NEWU). To learn more, visit newtopia.com, Facebook, LinkedIn or Twitter.

 

Forward Looking Information

 

This press release contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, and forward looking statements, within the meaning of applicable United States securities legislation (collectively, “forward-looking statements“), which reflects management’s expectations regarding Newtopia’s future growth, results from operations (including, without limitation, future production and capital expenditures), performance (both operational and financial) and business prospects and opportunities. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation or other variations thereof, or comparable terminology have been used to identify forward-looking statements. All statements other than statements of historical fact may be forward-looking ‎information. Such statements reflect Newtopia’s current views and intentions with respect to future ‎events, based on information available to Newtopia, and are subject to certain risks, uncertainties and ‎assumptions, including without limitation, the Company’s successful completion of its strategic technology projects (including on budget), continued and sustained high levels of client engagement and low client churn, the expansion of client relationships, the rollout of new clients, the conversion of pilot projects into full blown rollouts, the Company’s ability to continue to grow its sales pipeline, the ability of Nearwater to deliver on the milestones set out in the consulting agreement, and current financial trends remaining at or above the current levels in respect of revenue, gross profit, gross margin percentage and adjusted operating expenses. Material factors or assumptions were applied in providing forward-looking information. While forward-looking statements are based on data, assumptions and analyses that Newtopia believes are reasonable under the circumstances, whether actual results, performance or developments will meet Newtopia’s expectations and predictions depends on a number of risks and uncertainties that could cause the actual results, performance and financial condition of Newtopia to differ materially from its expectations.

 

These forward-looking statements include, among other things, clients continuing to offer Newtopia’s platform pursuant to agreements entered into, the timing and ability of the Company to successfully complete strategic technology projects (including on budget), continued and sustained high levels of client engagement and low client churn, the expansion of client relationships, the rollout of new clients, the conversion of pilot projects into full blown rollouts, the Company’s ability to continue to grow its sales pipeline, the ability of Nearwater to deliver on the milestones set out in the consulting agreement, the Company being confident that it will continue to increase its revenue, gross profit, gross margin percentage and adjusted operating expenses among other financial metrics and current financial trends remaining at or above current levels. Forward-looking statements are not a guarantee and are based on a number of estimates and assumptions management believes to be relevant and reasonable, whether actual results, performance or developments will meet Newtopia’s expectations and predictions depends on a number of risks and uncertainties that could cause the actual results, performance and financial condition of Newtopia to differ materially from its expectations. Certain of the “risk factors” that could cause ‎actual results to differ materially from Newtopia’s forward-looking statements in this press release ‎include, without limitation: the termination of contracts by clients, risks related to COVID-19 including various recommendations, orders and measures of ‎‎governmental authorities to try to limit the pandemic, including travel restrictions, border closures, ‎‎non-essential business closures, quarantines, self-isolations, shelters-in-place and social ‎distancing, ‎disruptions to markets, economic activity, financing, supply chains and sales channels, ‎and a ‎deterioration of general economic conditions including a possible national or global ‎recession; and other general economic, market and business conditions and factors, including the risk factors discussed or referred to in Newtopia’s disclosure documents, filed with the securities ‎regulatory authorities in certain provinces of Canada and available at www.sedar.com including Newtopia’s final long form prospectus dated March 30, 2020.

 

Should any factor affect Newtopia’s in an unexpected manner, or should assumptions underlying the forward- looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, Newtopia does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release, and Newtopia undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.

 

Non-GAAP Financial Measures

 

The Company’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS“). Management uses certain non-GAAP measures, which are defined in the appropriate sections of this press release, to better assess the Company’s underlying performance. These measures are reviewed regularly by management and the Company’s Board of Directors in assessing the Company’s performance and in making decisions about ongoing operations. In addition, we use certain non-GAAP measures to determine the components of management compensation. We believe that these measures are also used by investors as an indicator of the Company’s operating performance. Readers are cautioned that these terms are not recognized GAAP measures and do not have a standardized GAAP meaning under IFRS and should not be construed as alternatives to IFRS terms, such as net income.

 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

For further information, please contact:

 Chief Executive Officer:
Jeff Ruby, jruby@newtopia.com; 888-639-8181

Investor Contact:
Kimberly Esterkin, ADDO Investor Relations, investor@newtopia.com; 310-829-5400

 

 

NEWTOPIA INC.

Key Financial Measures and Schedule of Non-GAAP Reconciliations

 

Gross Profit Information [1]
Three Months Ended March 31,
2021 2020
$$
Revenue     2,619,171     3,862,986
Cost of sales    (1,300,867)    (2,208,557)
Gross profit     1,318,304     1,654,429
Gross margin50%43%

 

 

 

Reconciliation of Total Operating Expenses to Adjusted Operating Expense[2]
Three Months Ended March 31,
2021 2020
$$
Total operating expenses        3,594,792        3,162,510
Add (Subtract)
Share-based compensation          (549,820)          (134,432)
Depreciation of property and equipment            (17,972)            (21,554)
Depreciation of right-of-use asset            (46,195)            (46,192)
Interest and accretion expense                       –          (233,542)
Interest on lease obligations            (31,268)            (37,849)
Finance charges               (5,136)                       –
Amortization of deferred finance charges            (38,916)                       –
Foreign exchange gain            (27,796)            203,111
Change in value of convertible debenture derivative liabilities                       –          (270,993)
Change in value of derivative liability              44,519            (13,628)
Loss on settlement of related party payable                       –          (167,716)
Adjusted operating expenses        2,922,208        2,439,715

 

 

Adjusted Operating Loss [3]
Three Months Ended March 31,
2021 2020
$$
Gross profit1,318,3041,654,429
Adjusted operating expenses(2,922,208)(2,439,715)
(1,603,904)(785,286)

 

 

NEWTOPIA INC.

Condensed Interim Statements of Financial Position (Unaudited)

As at March 31, 2021 and December 31, 2020

(Expressed in Canadian Dollars)

 

March 31, 2021December 31, 2020
$$

Assets

Current assets

Cash    2,628,575         4,673,683
Trade and other receivables    1,093,674         1,067,123
Unbilled revenue        59,000 426,000
Prepaid expenses and deposits       594,656           465,285
Inventories       277,559           278,696
Deferred costs       204,163           232,089
    4,857,627         7,142,876
Property and equipment      111,941           129,913
Right‑of‑use asset      508,110 554,305
Intangible asset      540,441             68,948
    6,018,119         7,896,042

Liabilities

Current liabilities

Trade and other payables     2,646,488         2,765,583
Lease obligations        227,998           215,532
Derivative liability           2,989             47,508
     2,877,475         3,028,623

 

Non‑current lease obligations        596,565           667,558
     3,474,040         3,696,181

Equity

Common shares    45,177,120       44,648,952
Common shares to be issued          528,168
Contributed surplus    10,667,327       10,046,621
Deficit  (53,300,368)     (51,023,880)
     2,544,079         4,199,861
     6,018,119         7,896,042

 

 

NEWTOPIA INC.

Condensed Interim Statements of Loss and Comprehensive Loss (Unaudited)

Three Months Ended March 31, 2021 and 2020

(Expressed in Canadian Dollars)

 

20212020
$$
Revenue     2,619,171         3,862,986
Cost of revenue     1,300,867         2,208,557
Gross profit     1,318,304         1,654,429

 

Operating expenses

Technology and development        730,007           776,666
Sales and marketing        976,482           728,482
General and administrative     1,215,719           934,567
Share‑based compensation        549,820           134,432
     3,472,028         2,574,147

 

Other expenses (income)

Depreciation of property and equipment          17,972             21,554
Depreciation of right‑of‑use asset          46,195             46,192
Interest and accretion expense          233,542
Interest on lease obligations          31,268             37,849
Finance charges           5,136
Amortization of deferred finance charges          38,916
Foreign exchange loss (gain)          27,796         (203,111)
Change in value of convertible debenture derivative liabilities          270,993
Change in value of derivative liability        (44,519)             13,628
Loss on settlement of related party payable          167,716
        122,764           588,363

 

Net loss and comprehensive loss                                                            (2,276,488)       (1,508,081)

Loss per share

Basic and diluted          (0.02)             (0.10)

Weighted average number of common shares outstanding

Basic and diluted  100,492,786       15,535,919

 

 

NEWTOPIA INC.

Condensed Interim Statements of Changes in Equity (Unaudited)

Three Months Ended March 31, 2021 and 2020

(Expressed in Canadian Dollars)

 

  

 

Common SharesShares To Be IssuedPreferred SharesSpecial WarrantsContributed Surplus Deficit Total
 $$$$$$$
Balance, December 31, 2020   44,648,952             528,168    10,046,621    (51,023,880)      4,199,861
Net loss and comprehensive loss     (2,276,488)   (2,276,488)
Share‑based compensation       549,820       549,820
Issuance of shares       528,168          (528,168)
Settlement of related party payable         70,886         70,886
Balance, March 31, 2021   45,177,120    10,667,327    (53,300,368)      2,544,079

 

Balance, December 31, 2019    4,643,945     13,011,033     9,164,731     5,172,192    (43,204,384) (11,212,483)
Net loss and comprehensive loss     (1,508,081)   (1,508,081)
Share‑based compensation       134,432       134,432
Settlement of related party payable           528,168         39,548       567,716
Balance, March 31, 2020    4,643,945            528,168     13,011,033     9,164,731     5,346,172    (44,712,465) (12,018,416)

 

 

 

NEWTOPIA INC.

Condensed Interim Statements of Cash Flows

Three Months Ended March 31, 2021 and 2020

(Expressed in Canadian Dollars)

 

20212020
$$

Cash flows used in operating activities

Net loss and comprehensive loss   (2,276,488)       (1,508,081)
Depreciation of property and equipment          17,972             21,554
Depreciation of right‑of‑use asset          46,195             46,192
Amortization of deferred finance charges          38,916
Interest and accretion expense          233,542
Interest on lease obligations          31,268             37,849
Change in value of convertible debenture derivative liabilities          270,993
Change in value of derivative liability        (44,519)             13,628
Stock‑based compensation        549,820           134,432
Loss on settlement of related party payable          167,716
   (1,636,836)         (582,175)
Change in non‑cash working capital
Trade and other receivables        (26,551)         (134,275)
Unbilled revenue        367,000
Prepaid expenses and deposits      (129,371)           124,017
Inventories           1,137           248,122
Trade and other payables        (48,209)           141,294
   (1,472,830)         (203,017)

Cash flows used in investing activities

Purchase of property and equipment          (11,842)
Intangible asset development costs      (471,493)
      (471,493)           (11,842)

Cash flows used in financing activities:

Credit facility financing costs        (10,990)
Repayment of lease obligations        (89,795)           (64,213)
      (100,785)           (64,213)
Net change in cash during the period   (2,045,108)         (279,072)
Cash, beginning of period     4,673,683         2,386,341
Cash, end of period                                                               2,628,575         2,107,269

Supplemental cash flow information

Non‑cash settlement of debt          70,886 400,000

 

 

Scroll to Top